Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial
Background: Acute phase proteins disorders are common problems in dialysis patients. According to previous studies, carnitine can increase blood albumin levels in these patients. In this study the effect of carnitine on serum albumin level of hemodialysis patients was investigated. Methods: In this...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Vesnu Publications
2011-04-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/885 |
id |
doaj-82d0b4db4a174daa86b96de656198b0b |
---|---|
record_format |
Article |
spelling |
doaj-82d0b4db4a174daa86b96de656198b0b2020-11-25T02:34:23ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2011-04-012811914011408600Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical TrialMojgan Mortazavi0Shiva Seyrafian1Shahram Taheri2Afrouz Eshaghian3Maryam Ghesami4Isfahan Kidney Diseases Research Center, Assistant Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical sciences, Isfahan, IranIsfahan Kidney Diseases Research Center, Associate Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical sciences, Isfahan, IranIsfahan Kidney Diseases Research Center, Associate Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical sciences, Isfahan, IranMedical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranMedical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBackground: Acute phase proteins disorders are common problems in dialysis patients. According to previous studies, carnitine can increase blood albumin levels in these patients. In this study the effect of carnitine on serum albumin level of hemodialysis patients was investigated. Methods: In this blinded placebo controlled randomized clinical trial, 51 hemodialysis patients (16, 17 and 18 patients in the drug (carnitine), placebo and control groups, respectively) aged more than 21 years, were enrolled. L-carnitine (250 mg) and placebo pills were prescribed daily in three divided doses orally for 6 months. The control group received no drug. Serum albumin level in studied patients was measured before the study and every month after intervention. Findings: The mean serum albumin level at baseline in carnitine, placebo, and control groups was 3.87 ± 0.26, 3.88 ± 0.35, and 3.96 ± 0.45 g/dl, respectively. The mean serum albumin level at the end of the study in carnitine, placebo and control groups was 4.39 ± 0.54, 4.44 ± 0.78, and 3.84 ± 0.45, respectively. The mean serum albumin changes in three studied groups were significantly different before and after intervention (P < 0.05) due to the difference of control group with placebo and carnitine groups. There was no significant difference regarding side effects and mortality in carnitine and placebo groups (P > 0.05). Conclusion: Carnitine had not significant effect in serum albumin level. But considering the improvement was observed in carnitine and placebo groups comparing with control group, it could be suggested that it may be attributed to placebo effect and improvement of patients’ mood. Similar studies with higher doses of carnitine are recommended.http://jims.mui.ac.ir/index.php/jims/article/view/885HemodialysisCarnitineAlbumin |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
Mojgan Mortazavi Shiva Seyrafian Shahram Taheri Afrouz Eshaghian Maryam Ghesami |
spellingShingle |
Mojgan Mortazavi Shiva Seyrafian Shahram Taheri Afrouz Eshaghian Maryam Ghesami Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial مجله دانشکده پزشکی اصفهان Hemodialysis Carnitine Albumin |
author_facet |
Mojgan Mortazavi Shiva Seyrafian Shahram Taheri Afrouz Eshaghian Maryam Ghesami |
author_sort |
Mojgan Mortazavi |
title |
Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial |
title_short |
Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial |
title_full |
Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial |
title_fullStr |
Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial |
title_full_unstemmed |
Effect of L-Carnitine on Serum Albumin Level of Hemodialysis Patients; A Placebo Controlled Randomized Clinical Trial |
title_sort |
effect of l-carnitine on serum albumin level of hemodialysis patients; a placebo controlled randomized clinical trial |
publisher |
Vesnu Publications |
series |
مجله دانشکده پزشکی اصفهان |
issn |
1027-7595 1735-854X |
publishDate |
2011-04-01 |
description |
Background: Acute phase proteins disorders are common problems in dialysis patients. According to previous studies, carnitine can increase blood albumin levels in these patients. In this study the effect of carnitine on serum albumin level of hemodialysis patients was investigated.
Methods: In this blinded placebo controlled randomized clinical trial, 51 hemodialysis patients (16, 17 and 18 patients in the drug (carnitine), placebo and control groups, respectively) aged more than 21 years, were enrolled. L-carnitine (250 mg) and placebo pills were prescribed daily in three divided doses orally for 6 months. The control group received no drug. Serum albumin level in studied patients was measured before the study and every month after intervention.
Findings: The mean serum albumin level at baseline in carnitine, placebo, and control groups was 3.87 ± 0.26, 3.88 ± 0.35, and 3.96 ± 0.45 g/dl, respectively. The mean serum albumin level at the end of the study in carnitine, placebo and control groups was 4.39 ± 0.54, 4.44 ± 0.78, and 3.84 ± 0.45, respectively. The mean serum albumin changes in three studied groups were significantly different before and after intervention (P < 0.05) due to the difference of control group with placebo and carnitine groups. There was no significant difference regarding side effects and mortality in carnitine and placebo groups (P > 0.05).
Conclusion: Carnitine had not significant effect in serum albumin level. But considering the improvement was observed in carnitine and placebo groups comparing with control group, it could be suggested that it may be attributed to placebo effect and improvement of patients’ mood. Similar studies with higher doses of carnitine are recommended. |
topic |
Hemodialysis Carnitine Albumin |
url |
http://jims.mui.ac.ir/index.php/jims/article/view/885 |
work_keys_str_mv |
AT mojganmortazavi effectoflcarnitineonserumalbuminlevelofhemodialysispatientsaplacebocontrolledrandomizedclinicaltrial AT shivaseyrafian effectoflcarnitineonserumalbuminlevelofhemodialysispatientsaplacebocontrolledrandomizedclinicaltrial AT shahramtaheri effectoflcarnitineonserumalbuminlevelofhemodialysispatientsaplacebocontrolledrandomizedclinicaltrial AT afrouzeshaghian effectoflcarnitineonserumalbuminlevelofhemodialysispatientsaplacebocontrolledrandomizedclinicaltrial AT maryamghesami effectoflcarnitineonserumalbuminlevelofhemodialysispatientsaplacebocontrolledrandomizedclinicaltrial |
_version_ |
1724809117065805824 |